Your shopping cart is currently empty

SIAIS100 TFA is a potent BCR-ABL PROTAC degrader with a DC50 of 2.7 nM, used in chronic myeloid leukemia (CML) research [1].
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | SIAIS100 TFA is a potent BCR-ABL PROTAC degrader with a DC50 of 2.7 nM, used in chronic myeloid leukemia (CML) research [1]. |
| In vitro | SIAIS100 exhibits antiproliferative activity against K562 cells with an IC50 value of 12 nM [1]. It induces degradation of BCR-ABL by 81.78% and 91.20% at concentrations of 5 nM and 100 nM, respectively [1]. SIAIS100 (100 nM; 8 h) significantly decreases BCR-ABL in K562 cells [1]. SIAIS100 (100 nM; 6 h) causes persistent and robust degradation of BCR-ABL, maintaining a durable cellular response post drug removal [1]. Additionally, SIAIS100 (1-1000 nM) significantly reduces mutant G250E/T315I in a dose-dependent manner and inhibits BCR-ABL signaling in 32D cells, as assessed by p-BCR-ABL levels [1]. |
| Molecular Weight | 1004.46 |
| Formula | C46H51ClF5N9O7S |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.